Concepedia

Weekly Bortezomib, Pegylated Liposomal Doxorubicin, and Dexamethasone Is a Safe and Effective Therapy for Elderly Patients With Relapsed/Refractory Multiple Myeloma

Alessandro Gozzetti, Alberto Fabbri, Stefania Oliva, E Marchini, Monica Bocchia, Marzia Defina, Francesco Lauria

Clinical Lymphoma Myeloma & Leukemia · 2010 · 15 citations · 14 references

DOI

Concepts

References

14

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

Brian G.M. Durie, Sydney E. Salmon · Cancer · 1975 · 3K citations

A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma

Paul G. Richardson, Bart Barlogie, James R. Berenson et al. · New England Journal of Medicine · 2003 · 2.6K citations · Full text

International uniform response criteria for multiple myeloma

Brian G.M. Durie, J-L Harousseau, Jesús F. San Miguel et al. · Leukemia · 2006 · 2.6K citations

, , +3

Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma

Paul G. Richardson, Pieter Sonneveld, Michael W. Schuster et al. · New England Journal of Medicine · 2005 · 2.5K citations · Full text

Cancer incidence and mortality in Europe, 2004

Peter Boyle, Jacques Ferlay · Annals of Oncology · 2005 · 1.2K citations

, , +7